Clerkenwell Health raises £2.1m to test the new wave of psychedelics treatments

Clerkenwell Health a psychedelic-specialist clinical research organisation, has raised £2.1m in seed funding, bringing the total to date up to £2.5m, which will be used to get the London startup-based fully operational.

Leave a Comment

Your email address will not be published.

Generated by Feedzy